Details
Stereochemistry | RACEMIC |
Molecular Formula | C19H23ClN2 |
Molecular Weight | 314.852 |
Optical Activity | ( + / - ) |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CN1CCCN(CC1)C(C2=CC=CC=C2)C3=CC=C(Cl)C=C3
InChI
InChIKey=WEUCDJCFJHYFRL-UHFFFAOYSA-N
InChI=1S/C19H23ClN2/c1-21-12-5-13-22(15-14-21)19(16-6-3-2-4-7-16)17-8-10-18(20)11-9-17/h2-4,6-11,19H,5,12-15H2,1H3
Molecular Formula | C19H23ClN2 |
Molecular Weight | 314.852 |
Charge | 0 |
Count |
|
Stereochemistry | RACEMIC |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 1 |
E/Z Centers | 0 |
Optical Activity | ( + / - ) |
DescriptionSources: https://www.ncbi.nlm.nih.gov/pubmed/14409112Curator's Comment: description was created based on several sources, including
http://www.eisai.jp/medical/products/di/EPI/HC_T_EPI.pdf
Sources: https://www.ncbi.nlm.nih.gov/pubmed/14409112
Curator's Comment: description was created based on several sources, including
http://www.eisai.jp/medical/products/di/EPI/HC_T_EPI.pdf
Homochlorcyclizine (INN) is an antihistamine which has been marketed in Japan since 1965. It is used in the treatment of Itching sensation resulting from skin diseases (eczema or dermatitis, pruritus, drug eruption, toxic erythema and infant strophulus), urticaria and allergic rhinitis. Homochlorcyclizine hydrochloride possesses several pharmacological properties: 1) inhibits bradykinin-induced contractions of isolated guinea pig ileum; 2)partially blocks SRS-A (slow-reacting substance of anaphylaxis )- induced contractions in isolated guinea pig il eum. 3) Homochlorcyclizine hydrochloride completely inhibits histamine-induced contractions at a concentration of 0.1μg/mL, while it completely inhibits serotonin or acetylcholine- induced contractions at a concentration of 1μg/mL.
Originator
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Histamine H1-receptor antagonists, promethazine and homochlorcyclizine, increase the steady-state plasma concentrations of haloperidol and reduced haloperidol. | 2003 Apr |
|
Effect of (+) or (-) camphorsulfonic acid additives to the mobile phase on enantioseparations of some basic drugs on a Chiralcel OD column. | 2005 Aug 12 |
|
Simultaneous determination of ten antihistamine drugs in human plasma using pipette tip solid-phase extraction and gas chromatography/mass spectrometry. | 2006 |
|
A similarity search using molecular topological graphs. | 2009 |
|
Development of a list of potentially inappropriate drugs for the korean elderly using the delphi method. | 2010 Dec |
|
Profiling of a prescription drug library for potential renal drug-drug interactions mediated by the organic cation transporter 2. | 2011 Jul 14 |
Substance Class |
Chemical
Created
by
admin
on
Edited
Sat Dec 16 16:30:27 GMT 2023
by
admin
on
Sat Dec 16 16:30:27 GMT 2023
|
Record UNII |
N5MVC31W2N
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Brand Name | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29578
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
142860-95-5
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
SUPERSEDED | |||
|
CHEMBL1515447
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | |||
|
C034022
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | |||
|
934
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | |||
|
N5MVC31W2N
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | |||
|
m6041
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | Merck Index | ||
|
100000083965
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | |||
|
SUB08050MIG
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | |||
|
212-699-1
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | |||
|
DTXSID9045635
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | |||
|
3627
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | |||
|
1381
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | |||
|
848-53-3
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | |||
|
C81142
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | |||
|
25132
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY | |||
|
Homochlorcyclizine
Created by
admin on Sat Dec 16 16:30:28 GMT 2023 , Edited by admin on Sat Dec 16 16:30:28 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
SALT/SOLVATE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |